3rd Quarter - Termination
PODESTA GROUP, INC. for PHARMATHENE, INC.
Firm
Client
Income
$40,000
Expenses
—
Terminated
Sep 5, 2016
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Biodefense product development and acquisition issues S. 2055/H.R. 3299 - Medical Countermeasures Innovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSH HOLLY | — |
| AMY PELLEGRINO | — |
| ANNA KATHERINE WEINSTEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.